The purpose of this assignment is to reflect on how technology assists with the management of healthcare data to improve services and outcomes. This is a reflective paper that is intended to be completed after you have successfully completed Tableau VLab Activity 3.

In a 750-1,000 word reflective essay, discuss how health information technology assists with the management of health data. Include the following in your essay:

1. Describe the two online databases you worked with in VLab.
2. Describe how you utilized health information technologies, applications, tools, processes, and structures to manage health data.
3. Which specific analytics technologies are utilized most often by healthcare organizations?
4. Analyze and interpret the data from the Tableau VLab and explain how the data can be used to improve healthcare services and health-related outcomes and promote wellness among populations.

What are two cultural and two ethical elements included in sex trafficking prevention? What are two risk factors and two protective factors? How do the cultural and ethical elements and the risk and protective factors influence strategies, methods, and activities in sex trafficking prevention?

Cardiorespiratory endurance is often considered the key component of health-related physical fitness. Why is this the case? How can cardiorespiratory endurance be measured and how can it be improved? What activities, if any, do you participate in that are geared toward improving cardiorespiratory endurance? How does this kind of physical activity/exercise make you feel? Offer some suggestions for maintaining motivation to engage in activities that improve cardiorespiratory endurance.

Given the discussion in the article (link is below), please opine on how the drug discovery and biopharmaceutical product development process can be improved to better support evaluations of safety and efficacy for these products.

For example, should the approved indication(s) for use for new biomedical products be constrained to specific populations in which genetic analysis has been thoroughly analyzed as part of the clinical development process? Should all pivotal Phase III clinical trials be limited in scope with respect to the genetic composition of patients included within the study? Please justify your responses with examples from the article (link) below.

The nurse is administering a medication noted to be vicious. What additional step must be added? 0 Insert the needle at a 90-degree angle 0 Pull the skin laterally 0 Immediately remove the needle after the injection is complete. 0 Pull the skin taut What action best matches the evaluation phase of the nursing process? 0 Counting the apical pulse before giving a dose of the medication 0 Counting the apical pulse and checking the blood pressure after giving the dose of medication 0 Identifying " Decreased Cardiac Output" as a client problem, 0 Teaching the client about their cardiac medication 0 Developing an outcome that the heart rate will be between 60—100 after giving the medication A client is prescribed 500mg of acetaminophen, PO, once. How much medication will remain in the client’s body at 4 half-lives? (Enter your answer to the nearest hundredth decimal place).